Gastrointestinal Complications Depending on the Selectivity of Non-Steroidal Anti-Inflammatory Drug

Main Article Content

G.V. Dzyak
Yu.M. Stepanov
I.V. Kushnirenko

Abstract

The article deals with the problem of gastrointestinal complications during administration of nonsteroidal anti-inflammatory drugs, commonly used to treat a range of conditions, particularly rheumatic diseases. The results of own researches, which served to define the characteristics of changes in the state of gastric secretory function in patients receiving non-selective and selective anti-inflammatory agent and their comparative analysis, are provided. The data obtained demonstrated a certain contribution to the understanding of the mechanism of development of complications from the gastrointestinal tract when taken drugs of above group.

Article Details

How to Cite
Dzyak, G., Stepanov, Y., & Kushnirenko, I. (2013). Gastrointestinal Complications Depending on the Selectivity of Non-Steroidal Anti-Inflammatory Drug. GASTROENTEROLOGY, (1.47), 30–35. https://doi.org/10.22141/2308-2097.1.47.2013.86239
Section
Original Researches

References

Gupta S. Management of Nonsteroidal, Anti-inflammatory, Drug-Associated Dyspepsia / S. Gupta, K. McQuaid // Gastroenterology. — 2005. — Vol. 129, Issue 5. — P. 1711-1719.

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia (the Canadian Adult Dyspepsia Empiric Treatment — Prompt Endoscopy (CADET-PE) study) / A.B. Thomson, A.N. Barkun, D. Armstrong [et al.] // Aliment. Pharmacol. Ther. — 2003. — № 17. — P. 1481-1491

Etiological factors of duodenal and gastric ulcers / A. Uyanikoğlu, A. Danalioğlu, F. Akyüz [et al.] // Turk. J. Gastroenterol. — 2012 Apr. — 23 (2). — P. 99-103.

Bjarnason I. Gastrointestinal safety of NSAIDs and over-the-counter analgesics / I. Bjarnason // Int. J. Clin. Pract. Suppl. — 2013 Jan. — 178. — P. 37-42.

Wallace J.L. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? / J.L. Wallace // Physiol. Rev. — 2008. — № 88 (4). — P. 1547-1565.

Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346) / J.L. Wallace, G. Caliendo, V. Santagada [et al.] // Br. J. Pharmacol. — 2010. — № 159 (6). — P. 1236-1246.

Determinants of the short-term gastric damage caused by NSAIDs in man / I. Bjarnason, C. Scarpignato, K. Takeuchi [et al.] // Alimentary Pharmacology & Therapeutics. — 2007. — Vol. 26, Issue 1. — P. 95-106.

Managing the Adverse Effects of Nonsteroidal Anti-inflammatory Drugs / P. Patrignani, S. Tacconelli, A. Bruno [et al.]// Expert Rev. Clin. Pharmacol. — 2011. — № 4 (5). — P. 605-621.

Aantiinflammatory drug (NSAID) induced mucosal injuries in stomach and small intestine / H. Matsui, O. Shimokawa, T. Kaneko [et al.] // J. Clin. Biochem. Nutr. — 2011. — Vol. 48, № 2. — P. 107-111.

Present status and strategy of NSAIDs-induced small bowel injury / K. Higuchi, E. Umegaki, T. Watanabe [et al.] // J. Gastroenterol. — 2009. — № 44 (9). — P. 879-888.

Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study / L. Maiden, B. Thjodleifsson, A. Seigal [et al.] // Clin Gastroenterol Hepatol. — 2007 Sep. — 5 (9). — P. 1040-1045.

Lim Y.J. Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy / Y.J. Lim, Ch.-H. Yang // Clin. Endosc. — 2012 June. — 45 (2). — P. 138-144.

Reuter B.K. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation / B.K. Reuter, N.M. Davies, J.L. Wallace // Gastroenterology. — 1997 Jan. — 112 (1). — P. 109-117.

Nylander O. The impact of cyclooxygenase inhibition on duodenal motility and mucosal alkaline secretion in anaesthetized rats / O. Nylander // Acta Physiol. (Oxf.). — 2011. — № 201 (1). — P. 179-192.

Satoh H. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility / H. Satoh, K. Amagase, K. Takeuchi // J. Pharmacol. Exp. Ther. — 2012 Nov. — 343 (2). — P. 270-277.

Jarupongprapa S. Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis / S. Jarupongprapa, P. Ussavasodhi, W. Katchamart // J. Gastroenterol. — 2012. — Dec 4. — Режим доступу до джерела: http://link.springer.com/article/10.1007%2Fs00535-012-0717-6.

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study / F.E. Silverstein, G. Faich, J.L. Goldstein [et al.] // JAMA. — 2000 Sep 13. — 284 (10). — P. 1247-1255.

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs / van der Linden M.W., van der Bij S., Welsing P. [et al.] // Ann. Rheum. Dis. — 2009 May. — 68 (5). — P. 668-673.

Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis / T. Turajane, R. Wongbunnak, T. Patcharatrakul [et al.] // J. Med. Assoc. Thai. — 2009 Dec. — 92. — Suppl. 6. — P. S19-26.

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial / F.K. Chan, A. Lanas, J. Scheiman [et al.] // Lancet. — 2010 Jul 17. — 376 (9736). — P. 173-179.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 > >>